Up to 0.8% additional placebo-adjusted mean reduction from baseline in A1C when added to preexisting anti-diabetic monotherapy1,2
48% total mean LDL-C reduction from baseline when added to atorvastatin 10 mg2,3
Reduce both A1C and LDL-C in your patients without being systemically absorbed.2
A new way to take down
two with one. Offer a new
dosing option to your patients.
1. Fonseca VA, Rosenstock J, Wang AC, Truitt KE, Jones MR. Colesevelam HCI improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy. Diabetes Care. 2008;31(8):1479-1484.
2. Welchol (colesevelam HCI). Prescribing Information. Daiichi Sankyo, Inc., Parsippany, NJ, 2009.
3. Hunninghake D, Insull W Jr, Toth P, et al. Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively. Atherosclerosis. 2001;158:407-416.